The Pragmatic MBA for Scientific and Technical Executives

Liang Bertrand C.

ISBN 10: 0123979323 / ISBN 13: 9780123979322

Editore: Elsevier, 2012

Riguardo questo articolo

pp. xiv + 156. Codice articolo 1851438729

Dati bibliografici

Titolo: The Pragmatic MBA for Scientific and ...

Casa editrice: Elsevier

Data di pubblicazione: 2012

Legatura: Rilegato

Condizione: New

Descrizione articolo

Riassunto:

This primer enables professionals with technical expertise to collaborate with their business-side colleagues.  Emphasizing brevity and clarity, it gives technical staff answers to their most pressing questions about economics, finance, marketing, strategic decision-making, accounting, management, and related subjects.  It does not offer condensed 1st year MBA courses; instead, it presents streamlined concepts and insights that are easy enough to be accessible and challenging enough to hold one's interest.  Its examples from pharma, IT, aircraft/navigation, and other industries highlight problems that technical professionals face daily. Written by "one of them," its credibility makes it more useful than Internet resources. Because it concentrates on pragmatic (as opposed to academic) approaches to business, it empowers technical staff to stay with the conversation--and take it to a higher level.

Bertrand C. Liang, MD, PhD, MBA, is Managing Member of Forward Ventures and Forward Medical Sciences and Executive Director of Pfenex, Inc.  He is trained in molecular biology and genetics (PhD) and is a clinican (MD) with subspecialty training in neurology and oncology. 

• Creates frameworks and builds concepts enabling technical staff to work with their business colleagues
• Delivers content for pragmatic, immediate use, not condensed presentations of subjects from first year MBA curriculum
• Extends readers' grasp by posting additional resources at a freely-available website 

Informazioni sull?autore:

Bert Liang is trained in molecular biology and genetics (Ph.D.) and is a clinician (M.D.) with subspecialty training in both neurology and oncology. He possesses an MBA as well as corporate experience (currently Executive Director of Pfenex Inc.) and has more than 50 publications in both scientific and business subjects.